Machine learning may guide use of neoadjuvant therapy for pancreatic cancer

Machine learning algorithms can help predict positive resection margin and lymph node metastases among patients with pancreatic ductal adenocarcinoma, according to study results.The approach yielded greater positive predictive values than CT scan for both variables, findings presented at Society of Surgical Oncology Annual Meeting showed.“This hopefully can give providers the ability to identify patients with resectable pancreatic cancer who may benefit from neoadjuvant therapies,” researcher Jeremy Chang, MD, MS, surgery resident at University of Iowa Hospitals, said during aRead More

Generated by Feedzy